T1	intervention 10 25	oral clodronate
T2	intervention-participants 529 532	419
T3	control 537 544	placebo
T4	control-participants 548 551	432
T8	outcome 798 866	levels of serum N-terminal pro-peptide of type I procollagen (PINP)-
T5	condition 29 79	bone mass, bone turnover and subsequent metastases
T6	outcome 581 590	spine BMD
T7	outcome 678 691	total hip BMD
T9	eligibility 421 453	women with primary breast cancer
